WILLIAM BOYETT: Open Payments
NPI 1053366286 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 82 payments from 23 companies in 2025. Trend: 2023 $1,819 · 2024 $1,337 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $264 |
| ABBVIE INC. | 12 | $201 |
| Novo Nordisk Inc | 8 | $150 |
| Abbott Laboratories | 8 | $137 |
| Lilly USA, LLC | 6 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Medtronic, Inc. | 3 | $68 |
| Dexcom, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, NURTEC ODT, PREVNAR 20, MOUNJARO, REXULTI, JARDIANCE, Ozempic.
Industry payments across GA — which companies pay providers there.
